Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

LSX, Suite 201, Business Design Centre, 52 Upper St

  1. Events
  2. Venues
  3. LSX, Suite 201, Business Design Centre, 52 Upper St
Events at this venue
Today

LSX World Congress

The LSX World Congress is Europe's premier event for life science leaders, designed to connect senior decision-makers from biopharma, medtech, and healthtech sectors. It offers [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top